Prostate cancer is any malignant tumor that arises from cells in prostate tissue.
Some of the symptoms are:
Frequent urination that increases during the night
Pain in the pelvic area
Weak (requiring much effort to pass) and intermittent (no continuous flow) urination
Blood or seminal fluid in urine
Risk factors, among others, for this pathology, which only affect men:
Age (usually suffered by patients between 60 and 70 years old)
A diet too rich in animal fats
Genetic predisposition due to hereditary factors
Prostate cancer can be categorised as:
Early stage (stages I and II) Usually asymptomatic. In this stage “active surveillance” which consists of carrying out a series of checks to keep the cancer “under control” is usually recommended.
Localized state (stage III). In this stage the tumor is already of considerable size but is localized and not affecting other areas or organs. At this stage, you may undergo a procedure known as a prostatectomy, consisting of the removal of the prostate gland. This operation can be performed by open surgery (retropubic or perineal), laparoscopic or using robotic techniques such as the Da Vinci® robot, the most advanced and precise available.
The surgery is reinforced with radiotherapy (proton therapy, brachytherapy, beam of light…), hormonal therapies and, perhaps, with cryotherapy.
In the most severe stage of the disease (IV) when the cancer has spread (metastasis) you may have chemotherapy, radiotherapy or transurethral resection of the prostate surgery to help manage the symptoms.
The result varies depending on each patient, their physical condition and the tumour progression
If we are in the first two phases the probabilities of overcoming this disease are very high, most patients eradicate it.
The probabilities of being clean of cancer diminish according to the stage so there will be cases in which our treatment is focused on maintaining a quality of life as satisfactory as possible.
This will depend on the stage in which the disease has been detected. Your recovery time may range from a few weeks, two to three months or more, depending on your individual case, your doctor may specify a longer period of time.
If you came to us in the early stages, you may be able to return home after a few weeks or a month, although you will have to maintain a close follow-up with your medical team (in your country or in ours) to check your progress.
This is an overall survival, regardless of age, histological type or stage of disease.
According to data from the American Cancer Society, virtually 100% of men with prostate cancer confined to the prostate or with only local spread have a 5-year survival without treatment. In advanced stages of the disease, these figures decrease.
If stomach cancer is found before it has spread, the 5-year survival rate is usually higher, but it depends on the stage of the cancer found during surgery.
If the cancer is diagnosed and treated before it has spread from the stomach, the 5-year survival rate is 67%. If the cancer has spread to nearby tissues or organs or to regional lymph nodes, the 5-year survival rate is 31%. If the cancer has spread to a distant part of the body, the 5-year survival rate is 5%.
Survival has improved in recent decades (48% for cases diagnosed between 1980 and 1985, and 65.5% for those diagnosed between 1990 and 1994), and this trend is expected to continue.
According to the NIH (National Institutes of Health), it has gone from an overall 5-year survival of 66.1% for those diagnosed between 1975 and 1977 to 98.4% from 2008 and 2014.
Since the generalisation of the early diagnosis test for determining PSA levels in the blood, the incidence of tumours has increased, but so has overall survival, not only because very small tumours are diagnosed and treated with excellent prognosis, but also because of improved treatment. Austria, whose survival figures are the best in Europe, is the country on the continent where the early diagnosis programme for prostate cancer was first implemented.